New Insulin Delivery Device Employs COC Cartridge

Valeritas Holdings, Inc. launches wearable patch-like device for Type 2 diabetics, eliminating the need to take multiple daily shots.

Valeritas Holdings, Inc. launches wearable patch-like device for Type 2 diabetics, eliminating the need to take multiple daily shots.
Valeritas Holdings, Inc. launches wearable patch-like device for Type 2 diabetics, eliminating the need to take multiple daily shots.

[This story originally ran 1/30/2018]

Bridgewater, NJ-based Valeritas Holdings, Inc. introduced what it considers a game-changing insulin delivery device for patients with Type 2 diabetes. The V-Go® Wearable Insulin Delivery devicefeatures an injection-molded cartridge made of TOPAS®cyclic olefin copolymer (COC) from TOPAS Advanced Polymers.

The medical device is worn like a patch and can eliminate the need for taking multiple daily shots. The innovative V-Go Wearable Basal plus Bolus Insulin Delivery device is commercially available in the U.S.

Basal insulin is long-acting, and keeps blood glucose levels consistent between meals and during sleep. Fast-acting bolus insulin is typically taken at meal times to control blood sugar.

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO